Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions

Mov Disord. 2007 May 15;22(7):1020-3. doi: 10.1002/mds.21416.

Abstract

We report a patient with an autosomal dominant chronic progressive external ophthalmoplegia phenotype associated with multiple mtDNA deletions in muscle from a family in which linkage analysis excluded mutations in DNA polymerase gamma (POLG), adenine nucleotide translocase (ANT-1) or C10orf2 (Twinkle). She presented with prominent Parkinsonism characterized by prolonged benefit from levodopa (L-dopa) and the later development of L-dopa induced dyskinesias and motor fluctuations. Thus L-dopa responsiveness, L-dopa induced dyskinesias and motor fluctuations may also occur in atypical Parkinsonism of mitochondrial disease, just as they may in multiple system atrophy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiparkinson Agents / therapeutic use*
  • Chromosome Deletion*
  • DNA, Mitochondrial / genetics*
  • DNA, Mitochondrial / ultrastructure
  • Humans
  • Levodopa / therapeutic use*
  • Male
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / genetics
  • Parkinson Disease / pathology
  • Pharmacogenetics

Substances

  • Antiparkinson Agents
  • DNA, Mitochondrial
  • Levodopa